View in EDS

Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study.

Saved in:
Bibliographic Details
Title: Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study.
Authors: Fizazi, K.1 (AUTHOR) k-fizazi@o-lambret.fr, Clarke, N.W.2 (AUTHOR), De Santis, M.3,4 (AUTHOR), Uemura, H.5 (AUTHOR), Fay, A.P.6 (AUTHOR), Karadurmus, N.7 (AUTHOR), Kwiatkowski, M.8 (AUTHOR), Alvarez-Fernandez, C.9,10 (AUTHOR), Jiang, S.11 (AUTHOR), Sotelo, M.12 (AUTHOR), Parslow, D.13 (AUTHOR), Oliveira, N.14,15 (AUTHOR), Kwon, T.G.16 (AUTHOR), Ye, D.17 (AUTHOR), Boudewijns, S.18 (AUTHOR), Danchaivijitr, P.19 (AUTHOR), Rooney, C.20 (AUTHOR), Gresty, C.20 (AUTHOR), Yeste-Velasco, M.21 (AUTHOR), Logan, J.22 (AUTHOR)
Source: Annals of Oncology. Jan2026, Vol. 37 Issue 1, p53-68. 16p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.10.004